Phase 2 Acute Myelogenous Leukemia (AML) Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
A Phase 1B/2A Trial of NADUNOLIMAB in Combination With Azacitidine (With/Without Venetoclax) in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
Myelodysplastic Syndrome (MDS)Acute Myelogenous Leukemia (AML)
M.D. Anderson Cancer Center40 enrolled1 locationNCT06548230
Recruiting
Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
Fanconi AnemiaSevere Marrow FailureMyelodysplastic Syndrome (MDS)+1 more
Children's Hospital Medical Center, Cincinnati70 enrolled3 locationsNCT02143830
Recruiting
Phase 2
Cord Blood Transplant in Adults With Blood Cancers
Non-Hodgkin's LymphomaAcute Myelogenous Leukemia (AML)Myelodysplastic Syndromes (MDS)+3 more
Memorial Sloan Kettering Cancer Center54 enrolled1 locationNCT05884333